GSK1120212

GSK1120212
Item number Size Datasheet Manual SDS Delivery time Quantity Price
LKT-G7440.5 5 mg -

3 - 8 business days*

118.00€
LKT-G7440.25 25 mg -

3 - 8 business days*

218.00€
LKT-G7440.100 100 mg -

3 - 8 business days*

428.00€
 
GSK1120212 inhibits MEK1/2 and is currently in clinical trials as a potential treatment for... more
Product information "GSK1120212"
GSK1120212 inhibits MEK1/2 and is currently in clinical trials as a potential treatment for melanoma. GSK1120212 exhibits anticancer chemotherapeutic activity, upregulating p27 expression and inhibiting growth in colorectal cancer cells and suppressing tumor growth in colorectal cancer xenografts.
Keywords: Trametinib, JTP-74057
Supplier: LKT Laboratories
Supplier-Nr: G7440

Properties

Application: MEK1/2 inhibitor
MW: 615.39 D
Purity: >98%
Format: Solid

Database Information

CAS : 871700-17-3| Find alternatives
KEGG ID : K04369 | Find alternatives

Handling & Safety

Storage: +20°C
Shipping: +20°C (International: +20°C)
Signal Word: Danger
GHS Hazard Pictograms:
H Phrases: H317, H361, H372
P Phrases: P201, P202, P260, P261, P264, P270, P272, P280, P281, P302+P352, P308+P313, P314, P333+P313, P363, P405, P501
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "GSK1120212"
Write a review
or to review a product.
Viewed